Literature DB >> 18481725

[Study on protective action of electroacupuncture on endotoxin-induced hepatic injury in rats].

Xian Shi1, Qi Song, Sen Hu, Ze-Feng Li, Qian Liu, Lei Wang.   

Abstract

OBJECTIVE: To observe whether electroacupuncture (EA) at Zusanli (ST 36) reduces endotoxin-induced hepatic injury in rats and to explore the mechanism.
METHODS: Forty male SD rats were randomly divided into 4 groups, a endotoxin group, an EA group, a normal group and a non-acupoint group. Hepatic injury rat model was prepared by injection of endotoxin (5 mg/kg) into the caudal vein, the normal group received the injection of the equal amount of saline; for the EA group, EA (2-100 Hz, 2 mA, 1.5 h) was given at "Zusanli" (ST 36) half an hour after modeling, and for the non-acupoint group, acupuncture was given at the point 5 mm lateral to and 5 mm below "Zusanli" (ST 36), and other treatments were as same as those in the EA group.
RESULTS: Injection of endotoxin into the caudal vein could significantly increase TNF-alpha content in the liver and plasma ALT activity (P<0.01), which were decreased by EA (P<0.01) and were not significantly changed in the non-acupoint group (P>0.05).
CONCLUSION: The abnormal increases of TNF-alpha content in the liver and plasma ALT activity induced by endotoxin can be decreased by EA at "Zusanli" (ST 36), protecting the organ, and the mechanism is possibly related with the decrease of TNF-alpha content in the liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481725

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

1.  Investigation of hepatic blood perfusion by laser speckle imaging and changes of hepatic vasoactive substances in mice after electroacupuncture.

Authors:  Xiao-Jing Song; Dong Zhang; Shu-You Wang; Shun-Yue Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-21       Impact factor: 2.629

2.  Protective Effect of Electroacupuncture at Zusanli on Myocardial Injury in Septic Rats.

Authors:  Lijian Zhang; Zhenjun Huang; Xian Shi; Sen Hu; Daniela Litscher; Lu Wang; Gerhard Litscher
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.